Reported Sep 9, 2026 · Ongoing · Updated Sep 16, 2026

Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging,…

American Health Packaging

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: American Health Packaging · 2550 John Glenn Ave Ste A · Columbus, OH · 43217-1188

Is this the product you have?

  • Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only
  • Distributed byAmerican Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual
  • Dose NDC60687-481-11)
Lot codes and dates
  • Lot # 1030023
  • Exp Date06/30/2027
Amount recalled
10,953 cartons.

Where it was sold

  • Nationwide

Why it was recalled

Labeling: Label Mix-up

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new American Health Packaging recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (Enforcement Report)

Read the FDA (weekly enforcement report) notice

Notice updated Sep 14, 2026 · Data as of Sep 19, 6:53 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.